ilmscore | Prediction Details
"If it is approved, and it is the first application that that has been accepted uh by the FDA, if it is approved, it'll be the first pill form for these weight loss drugs out on the market."
By Let's Talk Money! with Joseph Hogue, CFA | August 19, 2025 | Pending
From video
Buy Heavy! This is How I Found the Next 158% Stock 00:07:51 - 00:08:03
Interpreted Prediction
Novo Nordisk's oral GLP-1 drug application is predicted to be approved by the FDA, making it the first pill form for weight loss drugs on the market.

Prediction Details

Ticker
NVO
Initial Price
54.78 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.